WO2006040451A2 - Nouveaux derives de 9h-pyrido (2, 3-b) indole en tant qu'inhibiteurs de cdk et gsk3 , leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes - Google Patents
Nouveaux derives de 9h-pyrido (2, 3-b) indole en tant qu'inhibiteurs de cdk et gsk3 , leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes Download PDFInfo
- Publication number
- WO2006040451A2 WO2006040451A2 PCT/FR2005/002474 FR2005002474W WO2006040451A2 WO 2006040451 A2 WO2006040451 A2 WO 2006040451A2 FR 2005002474 W FR2005002474 W FR 2005002474W WO 2006040451 A2 WO2006040451 A2 WO 2006040451A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pyrido
- novel
- compounds
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Description
--> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> -->
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0410683 | 2004-10-11 | ||
FR0410683A FR2876377B1 (fr) | 2004-10-11 | 2004-10-11 | Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006040451A2 true WO2006040451A2 (fr) | 2006-04-20 |
WO2006040451A3 WO2006040451A3 (fr) | 2006-06-08 |
Family
ID=34952217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2005/002474 WO2006040451A2 (fr) | 2004-10-11 | 2005-10-07 | Nouveaux derives de 9h-pyrido (2, 3-b) indole en tant qu'inhibiteurs de cdk et gsk3 , leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2876377B1 (fr) |
WO (1) | WO2006040451A2 (fr) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007044779A1 (fr) * | 2005-10-07 | 2007-04-19 | Takeda San Diego, Inc. | Inhibiteurs de kinase |
WO2007149557A1 (fr) | 2006-06-22 | 2007-12-27 | Cephalon, Inc. | [d]PYRIDAZIN-7-ONES CONDENSÉES |
WO2008045834A2 (fr) * | 2006-10-09 | 2008-04-17 | Takeda San Diego, Inc. | Inhibiteurs de kinases |
CN101573335A (zh) * | 2006-10-09 | 2009-11-04 | 武田药品工业株式会社 | 激酶抑制剂 |
JP2010505962A (ja) * | 2006-10-09 | 2010-02-25 | 武田薬品工業株式会社 | キナーゼ阻害剤 |
US7713973B2 (en) | 2004-10-15 | 2010-05-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
EP2223925A1 (fr) * | 2006-10-09 | 2010-09-01 | Takeda Pharmaceutical Company Limited | Inhibiteurs de kinase |
US7935823B2 (en) | 2007-09-20 | 2011-05-03 | D2E, Llc | Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
CN102203092A (zh) * | 2008-09-08 | 2011-09-28 | 米兰-比科卡大学 | NPM-ALK、RET和BCR-ABL的α-咔啉抑制剂 |
EP2662372A1 (fr) * | 2012-05-11 | 2013-11-13 | Università Degli Studi Di Milano - Bicocca | Alpha-carbolines pour le traitement du cancer |
WO2016037106A1 (fr) * | 2014-09-05 | 2016-03-10 | Allosteros Therapeutics, Inc | Inhibiteurs camkii et leurs utilisations |
US20170002005A1 (en) * | 2014-01-21 | 2017-01-05 | Ac Immune Sa | Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins |
CN108218862A (zh) * | 2018-02-07 | 2018-06-29 | 贵州医科大学 | α-卡波林类衍生物在制备抗心肌缺氧复氧损伤药物中的应用 |
JP2019529401A (ja) * | 2016-09-09 | 2019-10-17 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 2−(6−ニトロピリジン−3−イル)−9H−ジピリド[2,3−b;3’,4’−d]ピロールの製造方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2666138A1 (fr) * | 2006-10-09 | 2008-05-08 | Takeda Pharmaceutical Company Limited | Inhibiteurs de kinases |
WO2019149738A1 (fr) | 2018-01-31 | 2019-08-08 | Heparegenix Gmbh | Inhibiteurs de protéine kinase mkk4 pour favoriser la régénération hépatique ou pour réduire ou prévenir la mort des hépatocytes |
EP3810139A1 (fr) | 2018-06-21 | 2021-04-28 | HepaRegeniX GmbH | Inhibiteurs de protéine kinase tricycliques pour favoriser la régénération du foie ou réduire ou prévenir la mort des hépatocytes |
AU2019303986B2 (en) | 2018-07-16 | 2024-02-22 | Heparegenix Gmbh | Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
JP2023506215A (ja) * | 2019-12-18 | 2023-02-15 | ウニヴェルシテ ド モントリオール | 抗がん性化合物としてのCullin3アダプタKBTBD4モジュレータ |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997005137A1 (fr) * | 1995-07-31 | 1997-02-13 | Novo Nordisk A/S | Composes heterocycliques, et preparation et utilisation de ces derniers |
EP1388541A1 (fr) * | 2002-08-09 | 2004-02-11 | Centre National De La Recherche Scientifique (Cnrs) | Pyrrolopyrazines utilisées comme inhibiteurs de kinases |
FR2846329B1 (fr) * | 2002-10-23 | 2004-12-03 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique |
-
2004
- 2004-10-11 FR FR0410683A patent/FR2876377B1/fr not_active Expired - Fee Related
-
2005
- 2005-10-07 WO PCT/FR2005/002474 patent/WO2006040451A2/fr active Application Filing
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8288536B2 (en) | 2004-10-15 | 2012-10-16 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
US7713973B2 (en) | 2004-10-15 | 2010-05-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
EA015902B1 (ru) * | 2005-10-07 | 2011-12-30 | Такеда Фармасьютикал Компани Лимитед | Ингибиторы киназ |
US8318939B2 (en) | 2005-10-07 | 2012-11-27 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
EP2133349A1 (fr) * | 2005-10-07 | 2009-12-16 | Takeda San Diego, Inc. | Inhibiteurs de kinase |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
WO2007044779A1 (fr) * | 2005-10-07 | 2007-04-19 | Takeda San Diego, Inc. | Inhibiteurs de kinase |
WO2007149557A1 (fr) | 2006-06-22 | 2007-12-27 | Cephalon, Inc. | [d]PYRIDAZIN-7-ONES CONDENSÉES |
CN101501038B (zh) * | 2006-06-22 | 2012-07-18 | 赛福伦公司 | 稠合的[d]哒嗪-7-酮类化合物 |
EP2223925A1 (fr) * | 2006-10-09 | 2010-09-01 | Takeda Pharmaceutical Company Limited | Inhibiteurs de kinase |
WO2008045834A3 (fr) * | 2006-10-09 | 2008-07-24 | Takeda San Diego Inc | Inhibiteurs de kinases |
WO2008045834A2 (fr) * | 2006-10-09 | 2008-04-17 | Takeda San Diego, Inc. | Inhibiteurs de kinases |
CN101573335A (zh) * | 2006-10-09 | 2009-11-04 | 武田药品工业株式会社 | 激酶抑制剂 |
JP2010505962A (ja) * | 2006-10-09 | 2010-02-25 | 武田薬品工業株式会社 | キナーゼ阻害剤 |
US8278450B2 (en) | 2007-04-18 | 2012-10-02 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
US7935823B2 (en) | 2007-09-20 | 2011-05-03 | D2E, Llc | Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
JP2012501984A (ja) * | 2008-09-08 | 2012-01-26 | ウニヴェルシダ’デリ ストゥディ ディ ミラノ−ビコッカ | NPM−ALK、RETおよびBCR−ABLのα−カルボリン阻害剤 |
CN102203092A (zh) * | 2008-09-08 | 2011-09-28 | 米兰-比科卡大学 | NPM-ALK、RET和BCR-ABL的α-咔啉抑制剂 |
EP2662372A1 (fr) * | 2012-05-11 | 2013-11-13 | Università Degli Studi Di Milano - Bicocca | Alpha-carbolines pour le traitement du cancer |
WO2013167730A1 (fr) * | 2012-05-11 | 2013-11-14 | Universita' Degli Studi Di Milano - Bicocca | Alpha-carbolines pour le traitement du cancer |
US9428500B2 (en) | 2012-05-11 | 2016-08-30 | Universita Degli Studi Di Milano—Bicocca | Alpha-carbolines for the treatment of cancer |
US10662193B2 (en) * | 2014-01-21 | 2020-05-26 | Ac Immune Sa | Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins |
US20170002005A1 (en) * | 2014-01-21 | 2017-01-05 | Ac Immune Sa | Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins |
WO2016037106A1 (fr) * | 2014-09-05 | 2016-03-10 | Allosteros Therapeutics, Inc | Inhibiteurs camkii et leurs utilisations |
JP2017534572A (ja) * | 2014-09-05 | 2017-11-24 | アロステロス セラピューティクス, インコーポレイテッド | CaMKII阻害剤及びその使用 |
CN107074856A (zh) * | 2014-09-05 | 2017-08-18 | 阿略斯泰罗斯医疗公司 | CaMKII抑制剂及其用途 |
US10759792B2 (en) | 2014-09-05 | 2020-09-01 | The Johns Hopkins University | CaMKII inhibitors and uses thereof |
JP2020143161A (ja) * | 2014-09-05 | 2020-09-10 | ザ・ジョンズ・ホプキンス・ユニバーシティー | CaMKII阻害剤及びその使用 |
US11325908B2 (en) | 2014-09-05 | 2022-05-10 | The Johns Hopkins University | CaMKII inhibitors and uses thereof |
JP2019529401A (ja) * | 2016-09-09 | 2019-10-17 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 2−(6−ニトロピリジン−3−イル)−9H−ジピリド[2,3−b;3’,4’−d]ピロールの製造方法 |
US11306093B2 (en) | 2016-09-09 | 2022-04-19 | Hoffmann-La Roche, Inc. | Process for preparation of 2-(6-nitropyridin-3-yl)-9H-dipyrido[2,3-b;3′,4′-d]pyrrole |
CN108218862A (zh) * | 2018-02-07 | 2018-06-29 | 贵州医科大学 | α-卡波林类衍生物在制备抗心肌缺氧复氧损伤药物中的应用 |
CN108218862B (zh) * | 2018-02-07 | 2020-06-23 | 贵州医科大学 | α-卡波林类衍生物在制备抗心肌缺氧复氧损伤药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2006040451A3 (fr) | 2006-06-08 |
FR2876377B1 (fr) | 2007-03-16 |
FR2876377A1 (fr) | 2006-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006040451A2 (fr) | Nouveaux derives de 9h-pyrido (2, 3-b) indole en tant qu'inhibiteurs de cdk et gsk3 , leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes | |
WO2003053330A3 (fr) | Nouveaux composés | |
WO2006033007A3 (fr) | Formules polymorphes et amorphes de sel de phosphate de 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one | |
WO2007100366A3 (fr) | Modulateurs allostériques positifs du récepteur de la quinolone m1 | |
CY1108514T1 (el) | Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων | |
WO2003070236A3 (fr) | Derives de pyrazole tricyclique, procedes de leur preparation et leur utilisation en tant qu'agents anti-tumoraux | |
WO2008002244A8 (fr) | Nouveaux composés 384 | |
WO2006057945A3 (fr) | Derives pyridyle 2,3,4,6-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer | |
BRPI0513287A (pt) | derivados de pirido-pirimidina, sua preparação, sua aplicação em terapêutica | |
CA2498291A1 (fr) | Composes diazabicycliques utilises dans le traitement de troubles associes au snc | |
AU2002359162A1 (en) | Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 | |
CA2188427A1 (fr) | Stimulateurs de la liberation des neurotransmetteurs | |
WO2005003103A3 (fr) | Nouveaux heterocycles 2,4,6-trisubstitues et utilisations de ceux-ci | |
HK1104280A1 (en) | Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases | |
DK1181024T3 (da) | Anvendelse af glycosaminoglycaner til behandling af senil demens | |
WO2007017146A3 (fr) | Utilisation de la collismycine et de derives de celle-ci comme inhibiteurs du stress oxydatif | |
WO2005023833A3 (fr) | Traitement de maladies neurodegeneratives | |
WO2002060435A8 (fr) | Cryptotanshinone permettant de prevenir et d'attenuer la maladie d'alzheimer | |
WO2007019078A3 (fr) | Inhibiteurs de la beta-secretase tricyclique pour traiter la maladie d'alzheimer | |
WO2009151498A3 (fr) | Formulations de mémantine | |
WO2007034326A3 (fr) | Composes imidazoles pour le traitement de troubles neurologiques | |
WO2009134668A3 (fr) | Modulateurs allostériques positifs pour le récepteur m1 de 4-oxo-1,4-dihydroquinoléine | |
IL172229A (en) | Use of pyrzolopyridines for the preparation of medicinal products to improve cognitive perception | |
WO2007039174A3 (fr) | [1,3,4]-thiadiazol-2-yl-amides bicycliques de l'acide aryl-sulfonique, leurs procedes de preparation, et leur utilisation en tant que substances pharmaceutiques | |
WO2009117283A3 (fr) | Modulateurs allostériques positifs du récepteur m1 de la quinolizidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05809298 Country of ref document: EP Kind code of ref document: A2 |